Jan 2013 to Dec 2017 | Jan 2017 to Dec 2017
CHARGE CAPTURE ANALYSIS FOR DRG 847: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH COMPLICATION OR COMORBIDITY (CC) GROUP BASED ON MEDICARE | Back to Top |
| DRG Code | DRG Description | Category | Sub Category | DRG Group | Surgical Category | Case Mix Level | Total National Projected Hospitalizations - Annualized | Total Medicare Hospitalizations - Jan 2017 to Dec 2017 | Total Medicare Hospitalizations - Jan 2013 to Dec 2017 | Total Medicare Hospitalizations After Exclusion | Avg. LOS | GMLOS | All Cause Readmission Rate (%) | Unplanned Readmission Rate (%) | Total Medicare Payments | Payment per Day | Payment per Discharge | Total Medicare Charges | Avg. Charges | Mortality Rate (%) | SNF Discharge Rate (%) | Home Discharge Rate (%) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 847 | CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH COMPLICATION OR COMORBIDITY (CC) | Oncology & Hematology | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | Non Surgical | 78.09 | NA | 15,246 | 80,577 | 15,211 | ||||||||||||
| 848 | CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | Oncology & Hematology | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | Non Surgical | 1.94 | NA | 378 | 2,814 | 377 | ||||||||||||
| 846 | CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | Oncology & Hematology | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | Non Surgical | 19.97 | NA | 3,899 | 17,084 | 3,717 |
DEMOGRAPHIC DETAILS OF DRG 847: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH COMPLICATION OR COMORBIDITY (CC) | Back to Top |
| Race | Total Hospitalization Volume - Jan 2017 to Dec 2017 | % of DRG Volume |
|---|---|---|
| White | 12,576 | 82.49 |
| Black | 1,220 | 8.0 |
| Other | 357 | 2.34 |
| Age Group ( Years ) | Total Hospitalization Volume - Jan 2017 to Dec 2017 | % of DRG Volume |
|---|---|---|
| 65 to 69 | 4,924 | 32.3 |
| 70 to 74 | 4,027 | 26.41 |
| Less than 65 | 2,459 | 16.13 |
TOP ICD DIAGNOSIS CODES FOR DRG 847: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH COMPLICATION OR COMORBIDITY (CC) | Back to Top |
| ICD Code | ICD Description | Total ICD & DRG Hospitalization Volume - Jan 2017 to Dec 2017 | % of DRG Volume |
|---|---|---|---|
| Z5111 | Encounter for antineoplastic chemotherapy | 15,098 | 99.03 |
| T451X5A | Adverse effect of antineoplastic and immunosuppressive drugs, initial encounter | 3,156 | 20.7 |
| D6481 | Anemia due to antineoplastic chemotherapy | 2,505 | 16.43 |
TOP ICD PROCEDURE CODES FOR DRG 847: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH COMPLICATION OR COMORBIDITY (CC) | Back to Top |
| ICD Code | ICD Description | Total Procedure ICD & DRG Hospitalization Volume - Jan 2017 to Dec 2017 | % of DRG Volume |
|---|---|---|---|
| 3E04305 | Introduction of Other Antineoplastic into Central Vein, Percutaneous Approach | 6,674 | 43.78 |
| 3E03305 | Introduction of Other Antineoplastic into Peripheral Vein, Percutaneous Approach | 5,139 | 33.71 |
| 02HV33Z | Insertion of Infusion Device into Superior Vena Cava, Percutaneous Approach | 1,738 | 11.4 |
TOP HOSPITALS ASSOCIATED WITH DRG 847: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH COMPLICATION OR COMORBIDITY (CC) | Back to Top |
| Hospital Name | Address | City | State | Zip Code | Total Hospital & DRG Hospitalization Volume - Jan 2017 to Dec 2017 | % of DRG Volume |
|---|---|---|---|---|---|---|
| University of Texas MD Anderson Cancer Center | 1515 HOLCOMBE BLVD | Houston | TX | 77030 | 691 | 4.53 |
| Mayo Clinic Hospital - Saint Marys Campus | 1216 2ND ST SW | Rochester | MN | 55902 | 294 | 1.93 |
| Memorial Sloan Kettering Cancer Center | 1275 YORK AVE | New York | NY | 10065 | 260 | 1.71 |
TOP ATTENDING PHYSICIAN ASSOCIATED WITH DRG 847: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH COMPLICATION OR COMORBIDITY (CC) | Back to Top |
| Physician Name | Address | City | State | Zip Code | Total Physician & DRG Hospitalization Volume - Jan 2017 to Dec 2017 | % of DRG Volume |
|---|---|---|---|---|---|---|
| DR. VIKAS BHUSHAN | 7777 FOREST LN | DALLAS | TX | 75230 | 61 | 0.4 |
| DR. LORI ANN LESLIE | 1515 HOLCOMBE BLVD, UNIT 463 | HOUSTON | TX | 77030 | 58 | 0.38 |
| DR. HUN JU LEE | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | 53 | 0.35 |
TOP OPERATING PHYSICIAN ASSOCIATED WITH DRG 847: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH COMPLICATION OR COMORBIDITY (CC) | Back to Top |
| Physician Name | Address | City | State | Zip Code | Total Physician & DRG Hospitalization Volume - Jan 2017 to Dec 2017 | % of DRG Volume |
|---|---|---|---|---|---|---|
| DR. LORI ANN LESLIE | 1515 HOLCOMBE BLVD, UNIT 463 | HOUSTON | TX | 77030 | 52 | 0.34 |
| DR. HUN JU LEE | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | 49 | 0.32 |
| DR. LUIS E. FAYAD | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | 47 | 0.31 |
DRG 847: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH COMPLICATION OR COMORBIDITY (CC) SUMMARY TABLE | Back to Top |
| Category | Sub Category | DRG Group | ICD Codes | ICD Description | National Projected Hospitalizations (Present on Admission - All) Jan 2016 to Dec 2016 | Medicare Hospitalizations (Present on Admission - All) Jan 2017 to Dec 2017 | National Projected Hospitalizations(Present on Admission - Yes) Jan 2016 to Dec 2016 | Medicare Hospitalizations (Present on Admission - Yes) Jan 2017 to Dec 2017 | National Projected Hospitalizations (Present on Admission - Not Y) Jan 2016 to Dec 2016 | Medicare Hospitalizations (Present on Admission - Not Y) Jan 2017 to Dec 2017 | Total Discharges After Exclusion | Avg. LOS | GMLOS | All Cause Readmission Rate (%) | Unplanned Readmission Rate (%) | Total Medicare Payments | Payment per Day | Payment per Discharge | Total Medicare Charges | Avg. Charges | Mortality Rate (%) | SNF Discharge Rate (%) | Home Discharge Rate (%) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oncology & Hematology | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | Z5111 | Encounter for antineoplastic chemotherapy | 79,581 | 15,098 | |||||||||||||||||
| Oncology & Hematology | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | I10 | Essential (primary) hypertension | 21,475 | 7,210 | |||||||||||||||||
| Oncology & Hematology | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | E785 | Hyperlipidemia, unspecified | 9,452 | 4,615 | |||||||||||||||||
| Oncology & Hematology | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | Z87891 | Personal history of nicotine dependence | 11,849 | 4,493 | |||||||||||||||||
| Oncology & Hematology | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | T451X5A | Adverse effect of antineoplastic and immunosuppressive drugs, initial encounter | 15,538 | 3,156 | |||||||||||||||||
| Oncology & Hematology | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | K219 | Gastro-esophageal reflux disease without esophagitis | 8,627 | 3,130 | |||||||||||||||||
| Oncology & Hematology | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | D6481 | Anemia due to antineoplastic chemotherapy | 11,113 | 2,505 | |||||||||||||||||
| Oncology & Hematology | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | Z79899 | Other long term (current) drug therapy | 11,037 | 2,203 | |||||||||||||||||
| Oncology & Hematology | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | C8330 | Diffuse large B-cell lymphoma, unspecified site | 5,967 | 2,143 | |||||||||||||||||
| Oncology & Hematology | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | K5900 | Constipation, unspecified | 10,144 | 1,983 |